These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39394061)

  • 1. Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancers.
    Kren BT; Henzler CM; Ahmed K; Trembley JH
    Mol Med; 2024 Oct; 30(1):175. PubMed ID: 39394061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
    Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
    Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
    Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
    Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.
    Unger GM; Kren BT; Korman VL; Kimbrough TG; Vogel RI; Ondrey FG; Trembley JH; Ahmed K
    Mol Cancer Ther; 2014 Aug; 13(8):2018-29. PubMed ID: 24867250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
    Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
    Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
    Ahmed K; Kren BT; Abedin MJ; Vogel RI; Shaughnessy DP; Nacusi L; Korman VL; Li Y; Dehm SM; Zimmerman CL; Niehans GA; Unger GM; Trembley JH
    Oncotarget; 2016 Sep; 7(38):61789-61805. PubMed ID: 27557516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.
    Wang G; Unger G; Ahmad KA; Slaton JW; Ahmed K
    Mol Cell Biochem; 2005 Jun; 274(1-2):77-84. PubMed ID: 16342410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.
    Trembley JH; Unger GM; Korman VL; Tobolt DK; Kazimierczuk Z; Pinna LA; Kren BT; Ahmed K
    Cancer Lett; 2012 Feb; 315(1):48-58. PubMed ID: 22050909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase CK2 reduces Cyp24a1 expression and enhances 1,25-dihydroxyvitamin D(3) antitumor activity in human prostate cancer cells.
    Luo W; Yu WD; Ma Y; Chernov M; Trump DL; Johnson CS
    Cancer Res; 2013 Apr; 73(7):2289-97. PubMed ID: 23358686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
    Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 14. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.
    Xu W; Liu S; Ma L; Cheng L; Li Q; Qing L; Yang Y; Dong Z
    Comput Biol Med; 2024 Sep; 180():108989. PubMed ID: 39142223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
    Kim K; Chadalapaka G; Pathi SS; Jin UH; Lee JS; Park YY; Cho SG; Chintharlapalli S; Safe S
    Mol Cancer Ther; 2012 Sep; 11(9):1852-62. PubMed ID: 22752225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
    Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
    PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
    Wang G; Ahmad KA; Ahmed K
    Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice.
    Trembley JH; Unger GM; Korman VL; Abedin MJ; Nacusi LP; Vogel RI; Slaton JW; Kren BT; Ahmed K
    PLoS One; 2014; 9(10):e109970. PubMed ID: 25333839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells.
    Zaman MS; Johnson AJ; Petersingham G; Muench GW; Dong Q; Wu MJ
    Biometals; 2019 Dec; 32(6):861-873. PubMed ID: 31583500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.